Skip to content
healthcare.dev

ABREVA Rapid Pain Relief

NDC 0135-0400, glycerin, lidocaine, gel, from Haleon US Holdings LLC.

Product NDC
0135-0400
Status
Listed
Labeler
Haleon US Holdings LLC
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M017
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCERIN200 mg/g
  • LIDOCAINE HYDROCHLORIDE40 mg/g

Pharmacologic classes

Allergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Local Anesthesia [PE]; Non-Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
0135-0400-01001350400011 TUBE in 1 PACKAGE (0135-0400-01) / 3 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0135-0400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0135-0400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.